US › Healthcare

111 Inc (YI)

US · Healthcare · Medical Distribution

$3.86+6.72%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$2.36B

Revenue YoY

-33.1%

Net profit

$-37.0M

Profit YoY

-109.9%

EPS

$-0.26

Net margin

-1.6%

Key statistics

Market cap

$33.9M

Forward P/E

0.0

P/B

17.66

Book value

$-12.40

EPS (TTM)

$-7.63

52-week high

$8.53

52-week low

$2.48

50-day MA

$4.38

200-day MA

$5.19

Beta

0.63

Analyst view

with an average price target of $5.96.

Shareholding

Insiders

8.36%

Institutions

0.35%

Largest institutional holders

Fund	Stake
Renaissance Technologies Corp	0.15%
Serenus Wealth Advisors, LLC	0.05%
Citigroup Inc	0.00%
SBI Securities Co Ltd	0.00%
Morgan Stanley - Brokerage Accounts	0.00%
UBS Group AG	0.00%
JPMorgan Chase & Co	0.00%
Rhumbline Advisers	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for 111 Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.